MAPT and Alzheimer disease: An increased level of Thr231-phosphorylated tau protein in patient cerebrospinal fluid is associated with cognitive impairment, the accumulation of neurofibrillary tangles in the brain, and hippocampal atrophy, indicating progression from mild cognitive impairment to Alzheimer’s disease [67,69,96].